Sientra, Inc. (NASDAQ:SIEN) Given Average Recommendation of “Buy” by Brokerages

Shares of Sientra, Inc. (NASDAQ:SIENGet Rating) have been assigned a consensus recommendation of “Buy” from the nine analysts that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, one has given a hold rating and seven have issued a buy rating on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $8.21.

Several equities research analysts recently commented on SIEN shares. Zacks Investment Research lowered Sientra from a “hold” rating to a “sell” rating in a research report on Tuesday, March 29th. StockNews.com raised shares of Sientra from a “sell” rating to a “hold” rating in a research report on Friday, April 1st. UBS Group lowered their price objective on shares of Sientra from $10.00 to $8.00 and set a “buy” rating for the company in a research note on Tuesday, March 29th. Stifel Nicolaus cut their target price on shares of Sientra from $11.00 to $7.00 and set a “buy” rating on the stock in a research note on Thursday, March 24th. Finally, Canaccord Genuity Group decreased their price target on shares of Sientra from $10.00 to $8.00 and set a “buy” rating for the company in a research note on Tuesday, March 29th.

A number of institutional investors and hedge funds have recently modified their holdings of SIEN. Parkman Healthcare Partners LLC lifted its position in shares of Sientra by 46.4% during the 3rd quarter. Parkman Healthcare Partners LLC now owns 441,746 shares of the medical instruments supplier’s stock worth $2,531,000 after buying an additional 140,000 shares in the last quarter. OLD Mission Capital LLC purchased a new position in Sientra in the third quarter valued at approximately $219,000. Citigroup Inc. grew its holdings in Sientra by 135.5% during the third quarter. Citigroup Inc. now owns 6,435 shares of the medical instruments supplier’s stock valued at $37,000 after purchasing an additional 3,702 shares during the period. Mutual of America Capital Management LLC increased its position in Sientra by 31.3% in the fourth quarter. Mutual of America Capital Management LLC now owns 2,218,636 shares of the medical instruments supplier’s stock worth $8,142,000 after buying an additional 529,389 shares during the last quarter. Finally, Two Sigma Advisers LP lifted its position in shares of Sientra by 32.4% during the 3rd quarter. Two Sigma Advisers LP now owns 909,900 shares of the medical instruments supplier’s stock valued at $5,214,000 after buying an additional 222,700 shares during the last quarter. 89.48% of the stock is owned by hedge funds and other institutional investors.

Sientra stock opened at $1.99 on Monday. The firm has a market cap of $124.10 million, a price-to-earnings ratio of -1.16 and a beta of 1.99. Sientra has a 52-week low of $1.98 and a 52-week high of $9.14. The company has a debt-to-equity ratio of 1.53, a quick ratio of 1.10 and a current ratio of 1.76. The firm has a 50 day moving average price of $2.51 and a two-hundred day moving average price of $3.66.

Sientra (NASDAQ:SIENGet Rating) last released its earnings results on Wednesday, March 23rd. The medical instruments supplier reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by ($0.08). Sientra had a negative net margin of 112.89% and a negative return on equity of 865.36%. The firm had revenue of $22.65 million during the quarter, compared to analyst estimates of $22.50 million. During the same quarter in the previous year, the firm earned ($0.38) EPS. As a group, equities research analysts predict that Sientra will post -0.84 EPS for the current fiscal year.

About Sientra (Get Rating)

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

Featured Stories

Analyst Recommendations for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.